Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECONNECT-S GAMMA : A Non-interventional Study to Observe Real-life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia

NCT01491412 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01491412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01491412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECONNECT-S GAMMA : A Non-interventional Study to Observe Real-life Usage of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
May 31, 2012
Enrollment
503 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute psychotic episode, schizophrenia